Working... Menu

Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study (DolPHIN1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02245022
Recruitment Status : Active, not recruiting
First Posted : September 19, 2014
Last Update Posted : October 10, 2018
ViiV Healthcare
Makerere University
Information provided by (Responsible Party):
Catriona Waitt, University of Liverpool

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018